ARCHIVES

ODAC Prefers Three-Hour Taxol Infusion. Says Data Dosage Still Uncertain

This article is from The Cancer Letter archive.

Vol. 19 No. 38 | October 1, 1993

Download PDF Visit The Full Archive

Related Articles

In Brief: Gene Therapy Pioneer Michael Blaese To Leave NIH For Biotechnology Firm

January 16, 1998

Tamoxifen: No Mortality Benefit For Most “High Risk” Women

September 29, 2006

Gallo, Collaborators Map Entire Genetic Structure Of HTLV-III

January 25, 1985

In Brief: ‘WSJ” Articles Call Attention To Problems With Cancer Program Knipmeyer to Leave NCI

May 19, 1989

NEW OIG Awards Bring Total to 58

November 13, 1987

In Brief: Roper To Resign From CDC; Clinton Nominates Phillip Lee For Asst. Secretary For Health

March 19, 1993